Jeffrey Glassberg, MD

Dr. Jeffrey Glassberg is tenured Professor of Emergency Medicine and Medicine (Hematology and Medical Oncology) at the Icahn Sinai School of Medicine. He is also the Interim System Vice Chair for Research in the Department of Emergency Medicine. He obtained his MD and a Masters’ degree in clinical research at Washington University in St. Louis School of Medicine in 2006. Dr. Glassberg completed his emergency medicine residency at NYU/Bellevue in 2010, followed by a research fellowship at Mount Sinai in July of 2012. 

Dr. Glassberg has become a leader in promoting evidence based strategies for the acute management of Sickle Cell Disease. He has several research focuses within Sickle Cell including pulmonary complications of Sickle Cell Disease, novel biomarkers for vaso-occlusive crises, and novel agents for the prevention and treatment of vaso-occlusion. In addition to practicing as an attending in the ED, Dr. Glassberg also sees patients in Sickle Cell clinic and serves as the primary physician for many patients with Sickle Cell disease who are at Mount Sinai. He is also active regionally and nationally as a member of the Queens Sickle Cell Advocacy Network, the New York Sickle Cell Advisory Council and the Sickle Cell Disease Association of America.

Regional / National Committees / Advisory Boards:
New York State Sickle Cell Advisory Committee
Board of Directors, Queens Sickle Cell Advisory Committee
Medical and Research Advisory Committee: Sickle Cell Disease Association of America
2012 – present             Pain Committee, Mount Sinai Health System

Certifications
American Board of Emergency Medicine

Clinical Focus
Sickle Cell Disease
Hemoglobinopathies

Education

MD, MS Washington University
Internship, Emergency Medicine, Bellevue Hospital
Residency, Emergency Medicine, Bellevue Hospital